Stockscreener 앱 받기
5.87
10.65%
-0.70
시간 외 거래:
6.10
0.23
+3.92%
Clene Inc 주식(CLNN)의 최신 뉴스
Analysts Have Conflicting Sentiments on These Consumer Goods Companies: Hengan International Group Co (OtherHEGIF) and Clene (CLNN) - The Globe and Mail
Highs Report: What are the analyst revisions for INCYIs Clene Inc stock a good investment in YEAR - baoquankhu1.vn
Clene Secures Third-Year NIH Subaward for ALS Program - The Globe and Mail
Treasury Yields: Is Clene Inc Equity Warrant stock undervalued right nowPrice Action & Reliable Breakout Forecasts - baoquankhu1.vn
Nanotechnology Stocks To Watch TodayMarch 17th - MarketBeat
Clene Inc. Announces NIH Subaward Agreement for ALS Expanded Access Protocol – SEC Filing Details - Minichart
Clene Inc. 2025 Annual Report Highlights: Financial Performance, Risk Factors, and Future Outlook - Minichart
Clene 10-K: Revenue $0.2M, EPS $(2.65) — Net Loss $(26.17)M - TradingView
Clene (NASDAQ: CLNN) pushes CNM-Au8 toward accelerated ALS approval - Stock Titan
Clene Inc. (NASDAQ: CLNN) secures $8M Year 3 ALS grant funding - Stock Titan
Clene (CLNN) Projected to Post Earnings on Monday - MarketBeat
Q1 Earnings Estimate for Clene Issued By HC Wainwright - MarketBeat
Best Nanotechnology Stocks To ResearchMarch 15th - MarketBeat
Promising Nanotechnology Stocks Worth WatchingMarch 14th - MarketBeat
Analysts Offer Insights on Consumer Goods Companies: Clene (CLNN) and American Public Education (APEI) - The Globe and Mail
Clene Inc. (NASDAQ:CLNN) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Market Fear: Is Clene Inc a play on infrastructure spendingTrade Signal Summary & Precise Buy Zone Identification - baoquankhu1.vn
Clene (NASDAQ:CLNN) Receives Buy Rating from Canaccord Genuity Group - MarketBeat
CLNN: Canaccord Genuity Reaffirms Buy Rating with $48 Target | C - GuruFocus
Clene (NASDAQ:CLNN) Issues Earnings Results - MarketBeat
Clene (CLNN) Analyst Rating Maintained at "Buy" with $23 Target - GuruFocus
Clene (NASDAQ:CLNN) Receives Buy Rating from D. Boral Capital - MarketBeat
Clene Nanomedicine "CNM-Au8" Market size expansion of Several Folds by 2034 - openPR.com
Clene Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Clene (CLNN) Reports FY25 Revenue Beat and Prepares for Key FDA Meeting - GuruFocus
Clene Reports Full Year 2025 Financial Results and Recent Operating Highlights - Investing News Network
Biopharmaceutical company Clene Inc (CLNN) recently unveiled its new financing strategy—two potential additional financings totaling over $22 millions have completed structural design. This funding plan will enable the company’s operational cash flow to la - Bitget
Clene reports full-year 2025 results: $200k revenue, $26.2M net loss - TradingView
Clene (NASDAQ: CLNN) narrows 2025 loss and readies accelerated ALS NDA filing - Stock Titan
ALS drug CNM-Au8 links biomarker declines to survival, Clene plans FDA filing - Stock Titan
Top Nanotechnology Stocks To Keep An Eye OnMarch 11th - MarketBeat
Clene Inc. (CLNN) Reports Q3 Loss, Lags Revenue Estimates - MSN
Nanotechnology Stocks To ConsiderMarch 10th - MarketBeat
Aug Selloffs: What are the analyst revisions for INCYIs Clene Inc. stock a good investment in YEARNew Guidance & Consistent Growth Stock Picks - baoquankhu1.vn
Nanotechnology Stocks To Follow NowMarch 7th - MarketBeat
Aug Movers: Should I set a stop loss on Clene IncExit Point & Free Long-Term Investment Growth Plans - baoquankhu1.vn
Top Nanotechnology Stocks To ResearchMarch 6th - MarketBeat
Institution Moves: How do insiders feel about Clene IncQuarterly Risk Review & Capital Efficient Trading Techniques - baoquankhu1.vn
Nanotechnology Stocks To Follow TodayMarch 5th - MarketBeat
Best Nanotechnology Stocks Worth Watching – March 3rd - Defense World
CLNN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Promising Nanotechnology Stocks To Follow Today – March 2nd - Defense World
Investor Mood: Is Clene Inc Equity Warrant stock undervalued right nowPortfolio Performance Report & AI Driven Stock Movement Reports - baoquankhu1.vn
Best Nanotechnology Stocks Worth WatchingMarch 3rd - MarketBeat
Top Nanotechnology Stocks To Consider – March 1st - Defense World
Promising Nanotechnology Stocks To Follow TodayMarch 2nd - MarketBeat
Top Nanotechnology Stocks To ConsiderMarch 1st - MarketBeat
Update Recap: Is Clene Inc a play on infrastructure spendingJuly 2025 Retail & Stock Portfolio Risk Management - baoquankhu1.vn
Top Nanotechnology Stocks To Follow TodayFebruary 28th - MarketBeat
CLNN Should I Buy - Intellectia AI
Best Nanotechnology Stocks To Follow NowFebruary 27th - MarketBeat
Aug Swings: Is LXRX gaining market sharePortfolio Value Report & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Clene Touts FDA Path for ALS Drug CNM-Au8, Highlights Biomarkers, Extends Cash Runway - MarketBeat
CLNN: Strong biomarker and survival data for ALS therapy positions company for NDA filing and 2027 launch - TradingView
1.20%
0.06%
자본화:
|
볼륨(24시간):